Both in Biotechnology
Anavex Life Sciences vs enGene Therapeutics
Over the past year AVXL returned −85.1% and ENGN returned −78.8%; their daily moves had a correlation of 0.14.
AVXL −85.1% ENGN −78.8%Growth of $1, one year, split-adjusted
| Metric | AVXL | ENGN |
|---|---|---|
| Price | $1.19 | $1.53 |
| Market cap | $110.3M | $102.5M |
| Today | −8.46% | 0.00% |
| 1 month | −37.0% | −22.7% |
| 6 months | −64.2% | −78.9% |
| Year to date | −66.6% | −83.1% |
| 1 year | −85.2% | −79.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $118.3M | $241.0M |
| Dividend yield | — | — |
| Volatility (60d) | 73.1% | 51.8% |
| Short % of float | 14.0% | 3.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).